首页|期刊导航|中华医学杂志（英文版）|Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer

Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer

Ying Cheng Hui Li Liang Zhang Jing-Jing Liu Chang-Liang Yang Shuang Zhang

中华医学杂志（英文版）2021，Vol.134Issue(15)：1780-1788,9.

中华医学杂志（英文版）2021，Vol.134Issue(15)：1780-1788,9.DOI:10.1097/CM9.0000000000001560

Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer

Ying Cheng ¹Hui Li ²Liang Zhang ¹Jing-Jing Liu ¹Chang-Liang Yang ¹Shuang Zhang¹

作者信息

1. Department of Thoracic Oncology,Jilin Cancer Hospital,Changchun,Jilin 130012,China
2. Translational Oncology Research Lab,Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer,Jilin Cancer Hospital,Changchun,Jilin 130012,China
折叠

摘要

关键词

Non-small cell lung cancer/Programmed death-1/programmed death-ligand 1/Immune checkpoint inhibitor/Combination therapy

Key words

Non-small cell lung cancer/Programmed death-1/programmed death-ligand 1/Immune checkpoint inhibitor/Combination therapy

引用本文复制引用

Ying Cheng,Hui Li,Liang Zhang,Jing-Jing Liu,Chang-Liang Yang,Shuang Zhang..Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer[J].中华医学杂志（英文版）,2021,134(15):1780-1788,9.

基金项目

This study was supported by the Special Project for Significant New Drug Research and Development in the Major National Science and Technology Projects of China(No.2020ZX09201-024). （No.2020ZX09201-024）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航